复旦大学外事处
                港澳台事务办公室
宣讲会-南加大医疗决策分析硕士项目宣讲会

发布时间: 2018-11-09      访问次数: 10

南加大医疗决策分析硕士项目宣讲会

时间:12月3日周一中午12:30

地点:复旦大学邯郸校区马锦明楼109室

*该宣讲会需要提前注册http://uscshanghai.mikecrm.com/UKcNZF7 欢迎参加



Master of Science in Healthcare Decision Analysis

Program Overview:

The Master of Science in Healthcare Decision Analysis (HCDA) is a unique, interdisciplinary program designed to prepare graduates seeking to improve their business and analytical abilities to enter careers in the healthcare sector related to product value and pricing, international access and reimbursement, and competitive business intelligence. HCDA follows a strategic approach to learning and focuses on the intersection of health economics, global coverage and health delivery, and applied international health policy. The program provides an opportunity for students to be at the forefront of a field in which current insurers, the pharmaceutical industry, healthcare systems and consulting firms cannot find enough qualified individuals to meet demand.

  

Program Highlights:

  • Concentrated 1 weekends per-semester schedule ideal for working professionals

  • Adult education learning emphasizing case au dies, team projects, war games

  • Coursework suitable for most business, science, economic and industry professionals

  • No course prerequisites or pre-set order of classes

  • Flexible distance and classroom learning including 'on-demand' lectures

  • Top 10 nationally ranked USC School of Pharmacy, No. 1 ranked private pharmacy school

  

Areas of Specialization:

  • Biopharmaceutical Marketing

  • Business Intelligence

  • Health Economics

  • Managed Care

  • Policy Analysis

  • Pricing

  • Value, Access, and Reimbursement

  

Course Structure:

The HCDA program is structured for easy access to both full-time and part-time students, and to allow each of them to progress at their own pace. The completion of eleven courses totaling 33 units is a requirement for graduation. No thesis is required.

  

For more information, go to https://hcda.usc.edu/

  

Speaker Profiles:

Mr. Grant Lawless, RPh, MD

Program Director of M.S. in Healthcare Decision Analysis (HCDA) and M.S. in Biopharmaceutical Marketing (BPMK)

Associate Professor of Pharmaceutical and Health Economics, USC School of Pharmacy

  

Ms. Michelle Ton

Senior Program Administrator, Academic and Student Affairs

Healthcare Decision Analysis and Biopharmaceutical Marketing


  

南加大医疗决策分析硕士项目简介

南加州大学药学院的医疗决策分析硕士项目(MS in Healthcare Decision Analysis,简称HCDA)是全美首创的此类项目。

  

HCDA的课程设置兼具 “紧凑” 和 “跨领域两大特点,内容涵盖专业的数据分析、国际化渠道及偿付、产品估价及定价、医保设计及运作。课程极具强有竞争力的商业视野,尤其适合毕业后志在医药医疗领域发展的学生,为日益多元化的医药医疗领域做准备。

  

HCDA项目适合已经拥有医药学和医学专业学位的学生,和其他拥有应用科学、经济学、商科等学业背景的本科生。

  

注册:http://uscshanghai.mikecrm.com/UKcNZF7


外事处

2018-11-9


版权所有 © 复旦大学外事处暨港澳台事务办公室